Functional Characterization Experiment summary for ENCSR687CTB
doi:10.17989/ENCSR687CTB
Summary
- Status
- released
- Assay
- STARR-seq
- Biosample summary
- Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours
- Biosample Type
- cell line
- Replication type
- isogenic
- Treatments
- 1 μM Mapracorat for 4 hours
- Nucleic acid type
- RNA
- Library starting quantity
- 75µg
- Size range
- 900-1000
- Extraction method
- Qiagen RNA extraction
- Strand specificity
- Strand-specific (reverse)
- Platform
- Illumina NovaSeq 6000
- Controls
Attribution
ENCODE4 project
- Lab
- Tim Reddy, Duke
- Award
- UM1HG009428 (Tim Reddy, Duke)
- Project
- ENCODE
- Aliases
- tim-reddy:A549-wg-starrseq-Mapracorat
- Date submitted
- June 11, 2021
- Date released
- June 17, 2021
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Modifications | Library |
---|---|---|---|---|---|
1 | 4 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS385DUA | ENCGM016JFT | ENCLB210XNT |
2 | 3 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS685FQI | ENCGM016JFT | ENCLB475KUW |
2 | 1 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS685FQI | ENCGM016JFT | ENCLB021UZG |
4 | 1 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS158RJP | ENCGM016JFT | ENCLB980FDV |
1 | 3 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS385DUA | ENCGM016JFT | ENCLB744CPE |
2 | 2 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS685FQI | ENCGM016JFT | ENCLB582NNL |
3 | 4 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS959CPU | ENCGM016JFT | ENCLB777BRF |
1 | 1 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS385DUA | ENCGM016JFT | ENCLB082AHF |
2 | 4 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS685FQI | ENCGM016JFT | ENCLB162NOA |
3 | 2 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS959CPU | ENCGM016JFT | ENCLB526NYB |
1 | 2 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS385DUA | ENCGM016JFT | ENCLB934WRJ |
3 | 1 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS959CPU | ENCGM016JFT | ENCLB588HBV |
3 | 3 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS959CPU | ENCGM016JFT | ENCLB827DSG |
4 | 3 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS158RJP | ENCGM016JFT | ENCLB928QLN |
4 | 4 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS158RJP | ENCGM016JFT | ENCLB508PEF |
4 | 2 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM Mapracorat (agonist) for 4 hours | ENCBS158RJP | ENCGM016JFT | ENCLB175NDM |